针对脏衰竭治疗效果估计的目标试验方法方法的审查:系统评估协议
Jule Pinter1, David J Tunnicliffe2, Pooshwikaa Karunikaikumar3
1University Hospital Würzburg, 97080, Würzburg, Germany. pinter_j@ukw.de.
Systematic reviews
|November 15, 2024
概括
本系统性审查评估了脏衰竭研究的目标试验仿真. 它旨在提高随机试验不可行时治疗效果估计的可靠性,提供方法指导.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 临床流行病学 临床流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 随机试验经常排除患有功能衰竭的患者,限制了干预的证据.
- 目标试验仿真为估计功能衰竭治疗效果提供了一个替代方案.
- 对仿真研究的不一致报告挑战了研究结果的有效性.
研究的目的:
- 评估目标试验模拟在功能衰竭研究中的使用和适当性.
- 确定模拟目标试验的研究与不应用这些原则的研究.
- 为可靠报告治疗效果估计提供方法指南.
主要方法:
- 按照PRISMA-P指南进行系统审查.
- 在MEDLINE,Embase和参考列表中搜索到2023年7月.
- 两位作者对文章进行选择和数据提取,有第三位评论员对不同意见进行审查.
- 使用预先规定的数据表格进行偏差风险评估.
主要成果:
- 本节不适用,因为摘要描述的是系统审查的协议,而不是审查本身的结果.
结论:
- 将提供设计目标试验和建模假设的具体建议.
- 该审查旨在提高对功能衰竭干预措施治疗效果估计的可靠性.
- 当随机试验不可行时,指导将提高研究结果的清晰度和有效性.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Kaplan-Meier Approach
100
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100
Factors Affecting Renal Clearance: Renal Impairment
57
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
57
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67


